Entera Bio EB613 Positioned to be First Oral Bone-Building Agent for OsteoporosisTreatment
Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, held a conference call on June 30th on results
Oramed Oral COVID-19 Vaccine Maker Gets IRB Approval for Clinical Trial
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced several updates
Jerusalem PlayBeyondBio 2021 Launches with 9 Healthtech Startups
The second cohort of PlayBeyondBio 2021 was launched by Erel Margalit on July 13th , 2021 at the JVP campus in Jerusalem. PlayBeyondBio is a
Sonovia Aims to Make your Bedroom Safer for Sleep
A person’s bed linen can retain 17,000 times more bacteria than an average toilet seat within one week of use. That’s a frightening statistic, considering
Betalin Therapeutics chosen as 1 of top 5 Top Stem Cell Startups in the World!
After Startup Insights, a worldwide operating data science company headquartered in Austria, https://www.startus-insights.com/ analyzed 120 stem cell startups from around the world impacting the healthcare
Mirror Biologics Inc. Initiates AlloStim® Phase IIB Clinical Trial for Metastatic Colorectal Cancer
Mirror Biologics, Inc., a clinical stage immunotherapy company specializing in the development, manufacturing and clinical translation of next generation therapeutic in-situ cancer vaccines in which
RenalSense Partners with Medline on Clarity RMS
Jerusalem based RenalSense Ltd., a privately-held medical device company and developer of Clarity RMS™, and Medline Industries, Inc., a leading global healthcare manufacturer and distributor,
VizibleZone Provides COVID-19 Exposure Notification Solution to the Israeli National Water Company
Jerusalem-based Artificial Intelligence (AI) startup VizibleZone today announced a deal with Mekorot, Israel’s National Water Company, to use VizibleZone‘s high accuracy exposure notification technology in
VOTIS Subdermal Imaging Raises US$2.5 Million
Jerusalem based VOTIS Subdermal Imaging Technologies, Ltd. has raised US$2.5 million in a private placement of equity to a consortium of investors in Israel, Italy,
